By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Following a difficult 2011 on the stock market, particularly in the second half of the year, shares of publicly traded genomics tools firms jumped in the first month of 2012.

The GenomeWeb Daily News Index, which tracks the stocks of 31 firms in the genomics tools and molecular diagnostics markets, rose 15 percent in January.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The New York Times' George Johnson muses on cancer's roots in multicellularity.

The San Diego Union Tribune wonders whether Medicare is ready for personalized medicine.

Jun Wang, the chief executive of BGI, has stepped down.

In PNAS this week: human T cell editing with CRISPR, retrotransposons acting as insulators, and more.